ClearPoint Neuro Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	45.49	36.97	31.39	23.96	20.55	16.3
Revenue Growth	32.51%	17.78%	31.04%	16.56%	26.09%	27.05%
Cost of Revenue	17.56	14.28	12.27	10.34	7.02	5.18
Gross Profit	27.93	22.69	19.12	13.61	13.53	11.12
Selling, General & Admin	41.82	31.16	26.46	24.35	18.97	15.22
Research & Development	16.41	13.9	12.39	11.71	10.89	9.28
Operating Expenses	58.23	45.06	38.86	36.06	29.86	24.5
Operating Income	-30.3	-22.36	-19.73	-22.45	-16.33	-13.37
Interest Expense	-5.33	-2.39	-0.52	-	-0.08	-0.97
Interest & Investment Income	1.31	1.21	1.39	0.39	-	-
Other Non Operating Income (Expenses)	-0.05	-0.15	-0.04	-0.03	-0.02	-0.06
EBT Excluding Unusual Items	-34.37	-23.69	-18.9	-22.09	-16.44	-14.41
Merger & Restructuring Charges	-1.8	-1.8	-	-	-	-
Pretax Income	-36.17	-25.49	-18.9	-22.09	-16.44	-14.41
Income Tax Expense	-0.03	0.06	0.01	-	-	-
Net Income	-36.14	-25.54	-18.91	-22.09	-16.44	-14.41
Net Income to Common	-36.14	-25.54	-18.91	-22.09	-16.44	-14.41
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	30	28	27	25	24	21
Shares Outstanding (Diluted)	30	28	27	25	24	21
Shares Change	6.75%	4.76%	9.84%	1.75%	16.63%	30.82%
EPS (Basic)	-1.21	-0.90	-0.70	-0.90	-0.68	-0.69
EPS (Diluted)	-1.21	-0.90	-0.70	-0.90	-0.68	-0.69
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-33.22	-24.45	-9.23	-14.44	-16.42	-12.87
Free Cash Flow Per Share	-1.11	-0.86	-0.34	-0.59	-0.68	-0.62
Gross Margin	61.39%	61.38%	60.92%	56.83%	65.84%	68.24%
Operating Margin	-66.60%	-60.49%	-62.87%	-93.70%	-79.47%	-82.05%
Profit Margin	-79.43%	-69.08%	-60.26%	-92.21%	-79.97%	-88.41%
Free Cash Flow Margin	-73.02%	-66.13%	-29.39%	-60.27%	-79.90%	-78.93%
EBITDA	-29.02	-21.48	-18.75	-21.82	-16.09	-13.22
EBITDA Margin	-63.80%	-58.10%	-59.75%	-91.09%	-78.28%	-81.08%
D&A For EBITDA	1.28	0.88	0.98	0.63	0.24	0.16
EBIT	-30.3	-22.36	-19.73	-22.45	-16.33	-13.37
EBIT Margin	-66.60%	-60.49%	-62.87%	-93.70%	-79.47%	-82.05%
Revenue as Reported	45.49	36.97	31.39	23.96	20.55	16.3

SEC Filings: 10-K · 10-Q